Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System.

Vizcardo R, Klemen ND, Islam SMR, Gurusamy D, Tamaoki N, Yamada D, Koseki H, Kidder BL, Yu Z, Jia L, Henning AN, Good ML, Bosch-Marce M, Maeda T, Liu C, Abdullaev Z, Pack S, Palmer DC, Stroncek DF, Ito F, Flomerfelt FA, Kruhlak MJ, Restifo NP.

Cell Rep. 2018 Mar 20;22(12):3175-3190. doi: 10.1016/j.celrep.2018.02.087.

2.

A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2V617F positive polycythemia vera: a case report.

Pang Y, Gupta G, Yang C, Wang H, Huynh TT, Abdullaev Z, Pack SD, Percy MJ, Lappin TRJ, Zhuang Z, Pacak K.

BMC Cancer. 2018 Mar 13;18(1):286. doi: 10.1186/s12885-018-4127-x.

3.

Melanoma in patients with GATA2 deficiency.

Nguyen J, Alexander T, Jiang H, Hill N, Abdullaev Z, Pack SD, Hsu AP, Holland SM, Hickstein DD, Engels EA, Brownell I.

Pigment Cell Melanoma Res. 2018 Mar;31(2):337-340. doi: 10.1111/pcmr.12671. Epub 2017 Dec 10.

PMID:
29156497
4.

PD-1 Blockade in Mediastinal Gray-Zone Lymphoma.

Melani C, Major A, Schowinsky J, Roschewski M, Pittaluga S, Jaffe ES, Pack SD, Abdullaev Z, Ahlman MA, Kwak JJ, Morgan R, Rabinovitch R, Pan Z, Haverkos BM, Gutman JA, Pollyea DA, Smith CA, Wilson WH, Kamdar M.

N Engl J Med. 2017 Jul 6;377(1):89-91. doi: 10.1056/NEJMc1704767. No abstract available.

5.

Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment response.

Biswas R, Gao S, Cultraro CM, Maity TK, Venugopalan A, Abdullaev Z, Shaytan AK, Carter CA, Thomas A, Rajan A, Song Y, Pitts S, Chen K, Bass S, Boland J, Hanada KI, Chen J, Meltzer PS, Panchenko AR, Yang JC, Pack S, Giaccone G, Schrump DS, Khan J, Guha U.

Cold Spring Harb Mol Case Stud. 2016 Nov;2(6):a001263.

6.

High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis.

Thomas A, Chen Y, Steinberg SM, Luo J, Pack S, Raffeld M, Abdullaev Z, Alewine C, Rajan A, Giaccone G, Pastan I, Miettinen M, Hassan R.

Oncotarget. 2015 May 10;6(13):11694-703.

7.

CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma.

Olanich ME, Sun W, Hewitt SM, Abdullaev Z, Pack SD, Barr FG.

Clin Cancer Res. 2015 Nov 1;21(21):4947-59. doi: 10.1158/1078-0432.CCR-14-2955. Epub 2015 Mar 25.

8.

Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial.

Lopez-Chavez A, Thomas A, Rajan A, Raffeld M, Morrow B, Kelly R, Carter CA, Guha U, Killian K, Lau CC, Abdullaev Z, Xi L, Pack S, Meltzer PS, Corless CL, Sandler A, Beadling C, Warrick A, Liewehr DJ, Steinberg SM, Berman A, Doyle A, Szabo E, Wang Y, Giaccone G.

J Clin Oncol. 2015 Mar 20;33(9):1000-7. doi: 10.1200/JCO.2014.58.2007. Epub 2015 Feb 9.

9.

[Treatment of elderly patients with combination of coronary artery disease and aortic valve pathology].

Khubulava GG, Kozlov KL, Shishkevich AN, Mikhailov SS, Kravchuk VN, Kusai AS, Olexuk IB, Abdullaev ZM, Lukyanov NG, Dyakonov MM.

Adv Gerontol. 2015;28(4):775-779. Review. Russian.

PMID:
28509470
10.

Multifocal dysembryoplastic neuroepithelial tumours associated with refractory epilepsy.

Yang AI, Khawaja AM, Ballester-Fuentes L, Pack SD, Abdullaev Z, Patronas NJ, Inati SK, Theodore WH, Quezado MM, Zaghloul KA.

Epileptic Disord. 2014 Sep;16(3):328-32. doi: 10.1684/epd.2014.0680.

11.

Malignant round cell tumor of bone with EWSR1-NFATC2 gene fusion.

Sadri N, Barroeta J, Pack SD, Abdullaev Z, Chatterjee B, Puthiyaveettil R, Brooks JS, Barr FG, Zhang PJ.

Virchows Arch. 2014 Aug;465(2):233-9. doi: 10.1007/s00428-014-1613-7. Epub 2014 Jul 4.

PMID:
24993903
12.

Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas.

Nicolae A, Xi L, Pittaluga S, Abdullaev Z, Pack SD, Chen J, Waldmann TA, Jaffe ES, Raffeld M.

Leukemia. 2014 Nov;28(11):2244-8. doi: 10.1038/leu.2014.200. Epub 2014 Jun 20. No abstract available.

PMID:
24947020
13.

Von hippel-lindau disease associated pulmonary carcinoid with cranial metastasis.

Zhang C, Yang AI, Vasconcelos L, Moon S, Yang C, Nesvick CL, Saidkhodjaeva L, Abdullaev Z, Pack SD, Ghosh A, Chittiboina P, Heiss JD, Zhuang Z, Quezado MM, Zaghloul KA.

J Clin Endocrinol Metab. 2014 Aug;99(8):2633-6. doi: 10.1210/jc.2014-1732. Epub 2014 May 30.

14.

Characterization of fibroblast growth factor receptor 1 in small-cell lung cancer.

Thomas A, Lee JH, Abdullaev Z, Park KS, Pineda M, Saidkhodjaeva L, Miettinen M, Wang Y, Pack SD, Giaccone G.

J Thorac Oncol. 2014 Apr;9(4):567-71. doi: 10.1097/JTO.0000000000000089.

15.

Primary subcutaneous spindle cell Ewing sarcoma with strong S100 expression and EWSR1-FLI1 fusion: a case report.

Arnold MA, Ballester LY, Pack SD, Abdullaev Z, Merchant M, Tsokos MG.

Pediatr Dev Pathol. 2014 Jul-Aug;17(4):302-7. doi: 10.2350/14-03-1454-CR.1. Epub 2014 Apr 15.

PMID:
24735198
16.

Two Cases of Spinal, Extraosseous, Intradural Ewing's sarcoma/Peripheral Neuroectodermal Tumor: Radiologic, Pathologic, and Molecular Analysis.

Mardekian SK, Gandhe A, Miettinen M, Pack S, Curtis MT, Abdullaev Z.

J Clin Imaging Sci. 2014 Jan 30;4:6. doi: 10.4103/2156-7514.126050. eCollection 2014.

17.

Tumor derived vasculogenesis in von Hippel-Lindau disease-associated tumors.

Zhuang Z, Frerich JM, Huntoon K, Yang C, Merrill MJ, Abdullaev Z, Pack SD, Shively SB, Stamp G, Lonser RR.

Sci Rep. 2014 Feb 17;4:4102. doi: 10.1038/srep04102.

18.

ER/PR positive epidermotropic primary cutaneous eccrine carcinoma as a cutaneous manifestation of MEN 2B.

Aung PP, Ballester LY, Abdullaev Z, Pack SD, Cummins DL, Mahalingam M.

J Am Acad Dermatol. 2013 Dec;69(6):e310-2. doi: 10.1016/j.jaad.2013.08.001. No abstract available.

PMID:
24238193
19.

Early lesions of follicular lymphoma: a genetic perspective.

Mamessier E, Song JY, Eberle FC, Pack S, Drevet C, Chetaille B, Abdullaev Z, Adelaïde J, Birnbaum D, Chaffanet M, Pittaluga S, Roulland S, Chott A, Jaffe ES, Nadel B.

Haematologica. 2014 Mar;99(3):481-8. doi: 10.3324/haematol.2013.094474. Epub 2013 Oct 25.

20.

ERG expression in epithelioid sarcoma: a diagnostic pitfall.

Miettinen M, Wang Z, Sarlomo-Rikala M, Abdullaev Z, Pack SD, Fetsch JF.

Am J Surg Pathol. 2013 Oct;37(10):1580-5. doi: 10.1097/PAS.0b013e31828de23a.

21.

Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms.

Qi CF, Kim YS, Xiang S, Abdullaev Z, Torrey TA, Janz S, Kovalchuk AL, Sun J, Chen D, Cho WC, Gu W, Morse HC 3rd.

Int J Mol Sci. 2012;13(5):6204-19. doi: 10.3390/ijms13056204. Epub 2012 May 21.

22.

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita VM, Kaivorinne AL, Hölttä-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chiò A, Restagno G, Borghero G, Sabatelli M; ITALSGEN Consortium, Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ.

Neuron. 2011 Oct 20;72(2):257-68. doi: 10.1016/j.neuron.2011.09.010. Epub 2011 Sep 21.

23.

Expression of a testis-specific form of Gal3st1 (CST), a gene essential for spermatogenesis, is regulated by the CTCF paralogous gene BORIS.

Suzuki T, Kosaka-Suzuki N, Pack S, Shin DM, Yoon J, Abdullaev Z, Pugacheva E, Morse HC 3rd, Loukinov D, Lobanenkov V.

Mol Cell Biol. 2010 May;30(10):2473-84. doi: 10.1128/MCB.01093-09. Epub 2010 Mar 15.

24.

Epigenetic regulation of caspase-3 gene expression in rat brain development.

Yakovlev A, Khafizova M, Abdullaev Z, Loukinov D, Kondratyev A.

Gene. 2010 Jan 15;450(1-2):103-8. doi: 10.1016/j.gene.2009.10.008.

25.

Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer.

Smith IM, Glazer CA, Mithani SK, Ochs MF, Sun W, Bhan S, Vostrov A, Abdullaev Z, Lobanenkov V, Gray A, Liu C, Chang SS, Ostrow KL, Westra WH, Begum S, Dhara M, Califano J.

PLoS One. 2009;4(3):e4961. doi: 10.1371/journal.pone.0004961. Epub 2009 Mar 23.

26.

BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours.

D'Arcy V, Pore N, Docquier F, Abdullaev ZK, Chernukhin I, Kita GX, Rai S, Smart M, Farrar D, Pack S, Lobanenkov V, Klenova E.

Br J Cancer. 2008 Feb 12;98(3):571-9. doi: 10.1038/sj.bjc.6604181. Epub 2008 Jan 15. Erratum in: Br J Cancer. 2008 Feb 12;98(3):676.

27.

Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors.

Renaud S, Pugacheva EM, Delgado MD, Braunschweig R, Abdullaev Z, Loukinov D, Benhattar J, Lobanenkov V.

Nucleic Acids Res. 2007;35(21):7372-88. Epub 2007 Oct 25.

28.

Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome.

Kim TH, Abdullaev ZK, Smith AD, Ching KA, Loukinov DI, Green RD, Zhang MQ, Lobanenkov VV, Ren B.

Cell. 2007 Mar 23;128(6):1231-45.

29.

Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene.

Renaud S, Loukinov D, Abdullaev Z, Guilleret I, Bosman FT, Lobanenkov V, Benhattar J.

Nucleic Acids Res. 2007;35(4):1245-56. Epub 2007 Jan 31.

30.

Allele-specific binding of CTCF to the multipartite imprinting control region KvDMR1.

Fitzpatrick GV, Pugacheva EM, Shin JY, Abdullaev Z, Yang Y, Khatod K, Lobanenkov VV, Higgins MJ.

Mol Cell Biol. 2007 Apr;27(7):2636-47. Epub 2007 Jan 22.

31.

The potential of BORIS detected in the leukocytes of breast cancer patients as an early marker of tumorigenesis.

D'Arcy V, Abdullaev ZK, Pore N, Docquier F, Torrano V, Chernukhin I, Smart M, Farrar D, Metodiev M, Fernandez N, Richard C, Delgado MD, Lobanenkov V, Klenova E.

Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):5978-86.

32.

Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.

Hong JA, Kang Y, Abdullaev Z, Flanagan PT, Pack SD, Fischette MR, Adnani MT, Loukinov DI, Vatolin S, Risinger JI, Custer M, Chen GA, Zhao M, Nguyen DM, Barrett JC, Lobanenkov VV, Schrump DS.

Cancer Res. 2005 Sep 1;65(17):7763-74.

33.

Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes.

Vatolin S, Abdullaev Z, Pack SD, Flanagan PT, Custer M, Loukinov DI, Pugacheva E, Hong JA, Morse H 3rd, Schrump DS, Risinger JI, Barrett JC, Lobanenkov VV.

Cancer Res. 2005 Sep 1;65(17):7751-62.

34.

Familial cases of point mutations in the XIST promoter reveal a correlation between CTCF binding and pre-emptive choices of X chromosome inactivation.

Pugacheva EM, Tiwari VK, Abdullaev Z, Vostrov AA, Flanagan PT, Quitschke WW, Loukinov DI, Ohlsson R, Lobanenkov VV.

Hum Mol Genet. 2005 Apr 1;14(7):953-65. Epub 2005 Feb 24.

PMID:
15731119
35.

[Synthetic proteins with antiviral properties of alpha-interferons].

Chertkova RV, Abdullaev ZKh, Dolgikh DA, Zav'ialov VP, Kirpichnikov MP.

Bioorg Khim. 2003 May-Jun;29(3):258-68. Russian.

PMID:
12845801
36.

[Introduction of biologically active fragments of interferon-alpha2 and insulin into the artificial protein albebetin affects immunogenicity of the final construct].

Bocharova OV, Moshkovskiĭ SA, Chertikova RV, Abdullaev ZKh, Kolesanova EF, Dolgikh DA, Kirpichnikov MP.

Vopr Med Khim. 2002 Jan-Feb;48(1):94-102. Russian.

PMID:
12068502
37.

A cytochrome c mutant with high electron transfer and antioxidant activities but devoid of apoptogenic effect.

Abdullaev ZKh, Bodrova ME, Chernyak BV, Dolgikh DA, Kluck RM, Pereverzev MO, Arseniev AS, Efremov RG, Kirpichnikov MP, Mokhova EN, Newmeyer DD, Roder H, Skulachev VP.

Biochem J. 2002 Mar 15;362(Pt 3):749-54.

38.

Structure and stability of recombinant protein depend on the extra N-terminal methionine residue: S6 permutein from direct and fusion expression systems.

Uversky VN, Abdullaev ZK, Arseniev AS, Bocharov EV, Dolgikh DA, Latypov RF, Melnik TN, Vassilenko KS, Kirpichnikov MP.

Biochim Biophys Acta. 1999 Jul 13;1432(2):324-32.

PMID:
10407154
39.

[Expression of mutant horse cytochrome c genes in Escherichia coli].

Dolgikh DA, Latypov RF, Abdullaev ZKh, Kolov V, Roder H, Kirpichnikov MP.

Bioorg Khim. 1998 Oct;24(10):756-9. Russian.

PMID:
9929736
40.

[Effect of a biologically active interferon fragment on the structure of the synthetic protein carrier].

Afasizheva IIu, Dolgikh DA, Abdullaev ZKh, Latypov RF, Tiktopulo EI, Uverskiĭ VN, Ptitsyn OB, Kirpichnikov MP.

Biofizika. 1998 May-Jun;43(3):384-91. Russian.

PMID:
9702328
41.

[Circular permutation of Thermus thermophilus ribosomal protein S6 to artificial protein albebetin topology].

Latypov RF, Abdullaev ZKh, Badretdinov AIa, Bocharov EV, Mel'nik TN, Afasizheva IIu, Arsen'ev AS, Dolgikh DA, Uverskiĭ VN, Finkel'shteĭn AV, et al.

Mol Biol (Mosk). 1998 Jan-Feb;32(1):125-32. Russian. No abstract available.

PMID:
9566259
42.

Can grafting of an octapeptide improve the structure of a de novo protein?

Aphasizheva IY, Dolgikh DA, Abdullaev ZK, Uversky VN, Kirpichnikov MP, Ptitsyn OB.

FEBS Lett. 1998 Mar 20;425(1):101-4.

43.

S6 permutein shows that the unusual target topology is not responsible for the absence of rigid tertiary structure in de novo protein albebetin.

Abdullaev ZK, Latypov RF, Badretdinov AY, Dolgikh DA, Finkelstein AV, Uversky VN, Kirpichnikov MP.

FEBS Lett. 1997 Sep 8;414(2):243-6.

44.

[A case of Sievert-Kartagener syndrome].

Kudelia AP, Abdullaev ZD, Kasumov MM.

Klin Med (Mosk). 1988 Mar;66(3):120-1. Russian. No abstract available.

PMID:
3260638
45.

[Toxic-allergic reaction in a patient after hemilaryngectomy for cancer of the larynx].

Alimov AI, Razikov AA, Abdullaev ZM.

Vestn Otorinolaringol. 1987 Nov-Dec;(6):82-3. Russian. No abstract available.

PMID:
2964116

Supplemental Content

Loading ...
Support Center